Very long on OMER, but an ~20% decline from a new high 4 days ago, on no news, shouldn't we at least be concerned. And I would not consider this "normal volatility"
"Omeros Corporation (NASDAQ:OMER) – Investment analysts at Cantor Fitzgerald issued their FY2018 EPS estimates for Omeros Corporation in a research note issued to investors on Friday. Cantor Fitzgerald analyst E. Piros forecasts that the biopharmaceutical company will earn ($0.99) per share for the year. Cantor Fitzgerald has a “Hold” rating and a $15.00 price target on the stock."
Investor Relations Today at 11:30 AM Message body Thank you for the message. Management is aware of the “Art Doyle” article. It is false and actionable. Omeros is pursuing all legal remedies and is determined to hold all responsible parties fully accountable.
Sincerely, Omeros Investor Relations
Omeros Corporation | 201 Elliott Avenue West | Seattle, WA 98119 206-676-5000 | www.omeros.com
Note to self.....when a stock goes up about 10 days in a row, it might be time to lighten up a little. Still holding though, in fact added more yesterday (too early I guess)...............Kel
Hammered again right out of the gate
How come the EU partnership is taking so long. It's been 2 years at least?
Form S-8 filed on June 21st for 3,600,000 shares of dilution for Incentive Compensation. Insiders are filling their pockets while the going is good.
Insiders Cashing Out: Jacobsen - on 6/13 to 6/15, exercised options at $9.37 and then DUMPED 24,000 shares at $19.95 to $22.45
Don't shoot the messenger, but it feels like a secondary is about to hit! Buy it!!
GreatDayLoser has been pumping RAD since $8+ He took a shellacking on the dog stock. No thanks, GDLoser!
Hedgies are selling short the pending DISCOUNTED DILUTIVE OFFERING which they will then cover with the shares from the offering? It's easy money for the unseemly task of screwing some dumb butt baggies.
If the company is fraud, why did the FDA okay fast track. Also how come they are making more money each quarter. Come on people get real. There is nothing wrong, only that it's stock rose to fast or there could be a secondary stock offering.
Team. How about quit panicking! Spreading rumors only helps shorts. Posting speculations does not help longs. Let's be fact and results driven. RELAX
Think about this. 120,000 patients in US only, $50,000 per patient, that is $6 billions. How much is it worth? With FDA breakthrough, nothing is better than this.
Down 10% two days straight???
Buy my friends, buy!!!
The "Fool" even gets it!
Volatility is often the name of the game when it comes to small cap biopharma stocks. Wednesday's slide shouldn't cause investors to panic nor feel any differently about the company's prospects than they did a few weeks ago. What really matters for Omeros Corporation is the long-term performance of its budding drug pipeline.
PUMP by Seeking Alpha 6 days ago, now the DUMP. Whenever SA pumps it, you want to beat the scammers out the door. Their scam articles were banned by Yahoo.